Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death

Oncogene

Volumn 25, Issue 31, 2006, Pages 4370-4375

  Liu, L ^a   Andrews, L G ^a   Tollefsbol, T O ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

BMI1; Cancer stem cells; INK4A ARF; PcG proteins; Telomerase

Indexed keywords

POLYCOMB GROUP PROTEIN BMI1; PROTEIN; RETINOID; TELOMERASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENICITY; CELL CYCLE PROGRESSION; CELL DEATH; CONTROLLED STUDY; GROWTH RETARDATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ALVEOLUS CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

APOPTOSIS; CELL DEATH; CELL LINE, TUMOR; HUMANS; NEOPLASMS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; RNA INTERFERENCE;

EID: 33746218202     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209454     Document Type: Article

References (28)

1. Adhikary S, Eilers M. (2005). Nat Rev Mol Cell Biol 6: 635-645.
2. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. (2003). Proc Natl Acad Sci USA 100: 3983-3988.
3. Bea S, Tort F, Pinyol M, Puig X, Hernandez L, Hernandez S et al. (2001). Cancer Res 61: 2409-2412.
4. Blair A, Hogge DE, Ailles LE, Lansdorp PM, Sutherland HJ. (1997). Blood 89: 3104-3112.
5. Bruggeman SW, Valk-Lingbeek ME, van der Stoop PP, Jacobs JJ, Kieboom K, Tanger E et al. (2005). Genes Dev 19: 1438-1443.
6. Casillas MA, Brotherton SL, Andrews LG, Ruppert JM, Tollefsbol TO. (2003). Gene 16: 57-65.
7. Cohen KJ, Hanna JS, Prescott JE, Dang CV. (1996). Mol Cell Biol 16: 5527-5535.
8. Dimri GP, Martinez JL, Jacobs JJ, Keblusek P, Itahana K, Van Lohuizen M et al. (2002). Cancer Res 62: 4736-4745.
9. Haupt Y, Alexander WS, Barri G, Klinken SP, Adams JM. (1991). Cell 65: 753-763.
10. Itahana K, Zou Y, Itahana Y, Martinez JL, Beausejour C, Jacobs JJ et al. (2003). Mol Cell Biol 23: 389-401.
11. Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M. (1999a). Nature 397: 164-168.
12. Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, van Lohuizen M. (1999b). Genes Dev 13: 2678-2690.
13. Kakunaga T, Yamasaki H. (1985). Transformation Assay of Established Cell Lines: Mechanisms and Applications. IARC Scientific Publications, International Agency for Research on Cancer: Lyon.
14. Leung C, Lingbeek M, Shakhova O, Liu J, Tanger E, Saremaslani P et al. (2004). Nature 428: 337-341.
15. Liu L, Berletch JB, Green JG, Pate MS, Andrews LG, Tollefsbol TO. (2004). Mol Cancer Ther 3: 1003-1009.
16. Mihara K, Chowdhury M, Nakaju N, Hidani S, Ihara A, Hyodo H et al. (2006). Blood 107: 305-308.
17. Molofsky AV, He S, Bydon M, Morrison SJ, Pardal R. (2005). Genes Dev 19: 1432-1437.
18. Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ. (2003). Nature 425: 962-967.
19. Mori T, Kiyono T, Imabayashi H, Takeda Y, Tsuchiya K, Miyoshi S et al. (2005). Mol Cell Biol 25: 5183-5195.
20. Pardal R, Clarke MF, Morrison SJ. (2003). Nat Rev Cancer 3: 895-902.
21. Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL et al. (2003). Nature 423: 302-305.
22. Shakhova O, Leung C, Marino S. (2005). J Mol Med 83: 596-600.
23. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T et al. (2004). Nature 432: 396-401.
24. Takeda Y, Mori T, Imabayashi H, Kiyono T, Gojo S, Miyoshi S et al. (2004). J Gene Med 6: 833-845.
25. Terai M, Uyama T, Sugiki T, Li XK, Umezawa A, Kiyono T. (2005). Mol Biol Cell 16: 1491-1499.
26. van der Lugt NM, Domen J, Linders K, van Roon M, Robanus-Maandag E, te Riele H et al. (1994). Genes Dev 8: 757-769.
27. van Lohuizen M, Verbeek S, Scheijen B, Wientjens E, van der Gulden H, Berns A. (1991). Cell 65: 737-752.
28. Vonlanthen S, Heighway J, Altermatt HJ, Gugger M, Kappeler A, Borner MM et al. (2001). Br J Cancer 84: 1372-1376.